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Abstract. Conjunctival vessels were examined with a 
slit-lamp and the abnormalities were graded in 77 pa- 
tients with sickle cell diseases, including 48 with sickle 
cell anaemia, 17 with sickle cell Po-thalassaemia and 12 
with HbS/HbC disease. The study demonstrated the oc- 
currence of similar conjunctival vessel abnormalities for 
the three sickle cell diseases which are, however, more 
severe in HbS homozygotes than in the two bther geno- 
types. An increase of the severity of the vascular abnor- 
malities with the increase of patient age was also ob- 
served for HbS homozygotes. The data suggest that the 
Conjunctival lesions accumulate and increase in severity 
in a similar fashion as other tissue damages observed in 
sickle cell diseases. 
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Almost every organ may be affected by ~e abnor- 
mal rheological properties of the sickle erythro- 
cytes, and the eyes are no exception (Serjeant 
1985). Different types of retinal lesions may occur, 
which may cause transient or permanent visual 
loss (Goodman et al. 1957; Lieb et al. 1959; Serjeant 
1985; Roy et al. 1987; Bonanomi et al. 1988). The 
conjunctival vessels are also affected by the disease 
and a specific conjunctival vascular pattern has 
been described in sickle disease (Goodman et al. 
1957; Lieb et al. 1959; Geeraets & Guerry 1960; 
Munro & Walker 1960; Fink et al. 1961,1964; Paton 
1961, 1962; Comer & Fred 1964; Serjeant et al. 
1972; Nagpal et al. 1977). Although of little hnc- 
tional significance, these vascular abnormalities 
are of considerable interest since they allow the di- 
rect observation of the effects of sickling and other 
blood alterations upon small vessels (Knisely et al. 
1947; Fink et al. 1964). 
The diagnostic value of the conjunctival sign has 
been confirmed in several studies (Fink et al. 1961, 
1964; Paton 1961, 1962), especially for HbS ho- 
mozygotes, but at least two problems remain unre- 
solved. First, the seventy of the conjunctival le- 
sions associated with the different genotypes of 
sickle cell diseases has not been established. By 
pooling data from six different studies (Geeraets & 
Guerry 1960; Paton 1961, 1962; Comer & Fred 
1964; Serjeant et al. 1972; Nagpal et al. 1977) we 
note that only 58% of 64 patients with SC disease 
had Conjunctival changes as compared with 95% of 
248 HbS homozygotes, thus suggesting that pa- 
tients with SC diseases are less severely affected. 
Nevertheless, no consistent pattern can be de- 
duced from the only 6 HbS/P-thalassaemia pa- 
tients thus far reported in two different studies 
(Paton 1961, 1962). 
The abnormalities seem less prominent and 
more easily reversible in younger patients (Fink et 
al. 1961, 1962; Paton 1962; Serjeant et al. 1972). 
However, a direct relationship between age and 
the seventy of the conjunctival vessel changes has 
not been clearly established. 
We report the results of a study of the conjunc- 
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tiva of Brazilian patients with sickle cell diseases, 
which demonstrate that the changes are less severe 
in HbS/P"-thalamassaemia than in HbS homozy- 
gotes and that the abnormalities accumulate with 
increasing patient age. 
Material and Methods 
The investigations were performed on 77 patients 
with sickle cell diseases: 48 with sickle cell anemia 
(SS), 17 with sickle cell Po-thalamassaemia (S/P'- 
thal) and 12 with HbS/HbC disease (SC). The pa- 
tients ranged in age from 3 to 47 years. For com- 
parative purposes, 14 controls were also studied. 
Diagnosis was established in each case by clinical, 
laboratory and family studies. Hemoglobin con- 
centrations were measured with a TOA Hemo- 
globinometer and HbF was quantitated by alkali 
denaturation. HbA,, measured by elution after 
electrophoresis, was in the normal range in all SS 
patients, and was elevated in all S/P"-thal patients. 
HbS was identified by electrophoresis on cellulose 
acetate at alkaline pH and on agar-citrate, and by 
low solubility in concentrated phosphate buffer. 
The globin chain synthesis of peripheral blood re- 
ticulocytes (Costa & Zag0 1986) was unbalanced for 
all 17 patients with sickle cell S/P"-thal. All patients 
regularly attended the Hemoglobinopathy Outpa- 
tient Clinic and were not in crisis when evaluated 
nor had they been transfused in the previous 4 
months. 
The conjunctival observations were made inde- 
pendently by two ophthalmologists who did not 
know the history or diagnosis of the patient. The 
examinations were performed with a Zeiss slit- 
lamp with 12.5X oculars and magnifications of 
10 X or 16 X.  Each of the observers examined one 
eye, in order to avoid the effect of warming due to 
prolonged exposure of the conjunctiva to the slit- 
lamp heat. The examiner identified the most af- 
fected area of the bulbar conjunctiva, and classi- 
fied the abnormalities into five grades of seventy 
(from 0 to 4) according to the criteria of Serjeant et 
al. (1972): grade 0, normal conjunctival vascula- 
ture; grade 1, occasional abnormal long linear dila- 
tations of vessels connected to vascular network; 
grade 2, numerous linear dilatations, some appar- 
ently unconnected from background vascular net- 
work; grade 3, short linear dilatations in associ- 
ation with short, dark, truncated, and curved 
vessel segments frequently apparently uncon- 
nected to background vascular network; grade 4, 
multiple short, dark, truncated vessel segments ap- 
parently unconnected to background vascular net- 
work. The two examiners agreed on the classifica- 
tion of 77% of cases (57174 patients) who were 
evaluated by both of them. The difference was of 
one grade for 16 and two grades for only one of the 
remaining 17 cases. For the 17 cases where there 
was a difference in classification, the higher grade 
was utilized. 
Results 
The results are summarized in Tables 1 and 2. 
One SS patient and about one-fourth of the 
S/Po-thal and SC patients had no abnormalities 
(grade 0) of conjunctival vessels. The three controls 
who were not grade 0 had minimal (grade 1) alter- 
ations (in two cases the two observers had dis- 
agreed and assigned grades 0 and 1). For purposes 
of statistical analysis, the first three grades (0-2). 
Table 1. 
Conjunctival vessel abnormalities in patients with sickle cell diseases and normal controls. 
Grade I SS 1 S/P'-thal I SC 1 Controls 
0 1 ( 2.1%) 4 (23.5%) 3 (25.0%) 11 (78.6%) 
1 2 ( 4.2%) 3 (17.6%) 4 (33.3%) 3 (21.4%) 
2 1 ( 2.1%) 2 (11.8%) 1 ( 8.3%) 0 
3 10 (20.8%) 6 (35.3%) 4 (33.3%) 0 
4 34 (70.8%) 2 (11.8%) 0 0 





* Significantly different, x 2  =4.01; P <  0.05. 
S/P'-thal sc 
Median Range Median Range 
and the last two grades (3-4) were combined. The 
percentage of cases assigned grades 3 or 4 was 0% 
for controls, 33% (4/12) for SC, 47% (8/17) for S/po- 
thal and 92% (44/48) for SS homozygotes. The dis- 
tributions were significantly different for the three 
sickle cell genotypes (x' =23.6, P <  0.005), but the 
difference between the S/P"-thal and SC genotypes 
was not significant. 
The age distribution of the three patient groups 
according to the severity of the lesions were also 
Merent (Table 2). Thus, all of the 39 SS patients of 
more than 7 years had grades 3-4, whereas 11 of 
the 24 S/p"-thal and SC patients aged more than 7 
years had grades 3-4. The median age of patients 
with grades 3-4 is higher than those of patients 
with grades 0-2 for the three genotypes, and the 
difference was statistically significant for the SS pa- 
tients (median test, x' = 4.01, P < 0.05). The increas- 
ing seventy of the abnormalities with the increase 
of age for the group of SS homozygotes is rep- 
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Discussion 
The present study demonstrates that abnor- 
malities of the conjunctival vessels are qualitatively 
similar for the three different sickle cell diseases: 
HbS homozygotes, S/B"-thal and HbS/HbC dis- 
ease. The lesions are, however, more severe in HbS 
homozygotes than in the two other genotypes. Al- 
though a difference between HbS/HbC and S/po- 
thal was not demonstrable, presumably because of 
the number of patients, our data suggest that S/po- 
thal patients may be more severely affected than 
those with HbS/HbC disease. 
An increase of the seventy of the vascular abnor- 
malities with the increase of patient age was dem- 
0 
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onstrated for SS homozygotes. This is in agree- 
ment with isolated observations reporting more 
benign lesions which are more easily reversible in 
younger patients (Fink et al. 1961, 1964; Paton 
1962; Serjeant et al. 1972). All of our SS patients of 
more than 7 years of age (39/39) had grade 3-4 
conjunctival lesions whereas in the 3-6 year range 
only 5/9 patients had grades 3-4. 
A significant correlation between severity of 
conjunctival vessel changes and counts of irrever- 
sibly sickled cells (ISC) has been reported for sickle 
cell diseases (Serjeant et al. 1972; Nagpal et al. 
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Fig 1. 
Grade of conjunctival vessel lesion for HbS homozygotes 
classified according to the criteria of Serjeant et al. (1972) 
as compared with patient age. 
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should not be taken as an indication of a causal re- 
lationship. Actually, many determinants of a low 
ISC are also determinants of a more benign clinical 
course and of fewer vasoocclusive episodes. Once 
the faster decrease of HbF concentration of the ne- 
onatal period has stabilized between 1-3 years of 
age, the severity of the disease will be determined 
mainly be a combination of genetic factors (such as 
HbF levels after stabilization, the mean corpuscu- 
lar haemoglobin and the presence of HbC, HbD or 
thalassaemia) (Sejeant 1985) and this will deter- 
mine the frequency of vasoocclusive phenomena 
and the rate of chronic tissue damage. Although 
the postnatal decrease of HbF levels is slower in 
sickle cell diseases than in normals, most of these 
patients have already reached almost stable adult 
HbF levels and all had developed a full clinical pic- 
ture at the time that they were evaluated. Thus, the 
lower grade of lesions for the patients at the lower 
age range does not seem to depend on a direct pro- 
tective effect of high HbF levels at the moment of 
evaluation. The data suggest that the conjunctival 
lesions accumulate and increase in severity in a 
similar fashion as other tissue damages caused by 
vasoocclusion (Serjeant 1985), such as proliferative 
retinopathy, splenic hypofunction and atrophy 
(Zago & Bottura 1983), and leg ulcers. 
Thus, similar vascular changes, including those 
of the conjunctivae, are observed in the three most 
common sickle cell diseases, but they occur and 
accumulate earlier in HbS homozygotes and later 
or with less seventy in S/@"-thal or HbS/HbC dis- 
ease. 
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